Semnur Pharmaceuticals, Inc. (SMNR) › Total AssetsSemnur Pharmaceuticals, Inc. (SMNR) — Total AssetsAnnual figures by period end, from SEC filings.2022-12-31: $86.28M2023-12-31: $50.69M2024-12-31: $6.68M2025-12-31: $1.35M$1.35M2022-12-31Total Assets (USD)2025-12-31Period endedTotal AssetsChange YoYSource filing2025-12-31$1.35M-79.9%2026-02-27Balance as of period end2024-12-31$6.68M-86.8%2026-02-27Balance as of period end2023-12-31$50.69M-41.3%2025-04-02Balance as of period end2022-12-31$86.28M—2024-04-01Balance as of period endOther metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)